Creatinine BSA Conjugate Solution

<strong>Creatinine BSA Conjugate solution.</strong>_x000D_ <table width="643">_x000D_ <tbody>_x000D_ <tr>_x000D_ <td>Catalog number:</td>_x000D_ <td>P2010017</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Lot number:</td>_x000D_ <td>Batch Dependent</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Expiration date:</td>_x000D_ <td>Batch Dependent</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Molecular Weight:</td>_x000D_ <td>70 kDa (Average)</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Purity:</td>_x000D_ <td>&gt; 95% by SDS-PAGE</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Concentration:</td>_x000D_ <td>1 mg/mL</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Package Size:</td>_x000D_ <td>0.5 mg</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Appearance:</td>_x000D_ <td>Clear Solution</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Storage:</td>_x000D_ <td>-20°C. Avoid repeated freeze-thaw.</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Other names:</td>_x000D_ <td>BSA-Creatinine, Creatinine-BSA, BSA conjugated to Creatinine, Creatinine Bovine Serum Albumin Conjugate, Creatinine [BSA].</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Keywords:</td>_x000D_ <td>Creatinine BSA Conjugate, 2-Imino-1-methylimidazolidin-4-one, 1-Methylglycocyamidine, 1-Methylhydantoin-2-imide.</td>_x000D_ </tr>_x000D_ </tbody>_x000D_ </table>_x000D_ &nbsp;_x000D_ _x000D_ <strong>References</strong>_x000D_ <ul>_x000D_ <li>Deng H, Fan Y, Yuan F, Wang L, Hong Z, Zhan J, Zhang W. Partial nephrectomy provides equivalent oncologic outcomes and better renal function preservation than radical nephrectomy for pathological T3a renal cell carcinoma: A meta-analysis. <span class="jrnl" title="International braz j urol : official journal of the Brazilian Society of Urology">Int Braz J Urol</span>. 2020 Apr 3;46.</li>_x000D_ <li>Sridhar VS, Rahman HU, Cherney DZI. What have we learned about renal protection from the cardiovascular outcome trials and observational analyses with SGLT2 inhibitors? <span class="jrnl" title="Diabetes, obesity &amp; metabolism">Diabetes Obes Metab</span>. 2020 Apr;22 Suppl 1:55-68.</li>_x000D_ <li>Razmpoosh E, Safi S, Abdollahi N, Nadjarzadeh A, Nazari M, Fallahzadeh H, Mazaheri M, Salehi-Abargouei A. The effect of Nigella sativa on the measures of liver and kidney parameters: A systematic review and meta-analysis of randomized-controlled trials. <span class="jrnl" title="Pharmacological research">Pharmacol Res</span>. 2020 Mar 20;156:104767.</li>_x000D_ <li>Weir MR, McCullough PA, Buse JB, Anderson J. Renal and Cardiovascular Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease: Perspectives on the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial Results. <span class="jrnl" title="American journal of nephrology">Am J Nephrol</span>. 2020;51(4):276-288.</li>_x000D_ <li>Shayganfar A, Moradi M, Moshiri R, Khosravi A, Ebrahimian S. Is High Preprocedural Renal Resistive Index Sensitive Enough to Predict Iodine Contrast-Induced Nephropathy in Patients Receiving Intra-Arterial Iodinate Contrast? <span class="jrnl" title="Current problems in diagnostic radiology">Curr Probl Diagn Radiol</span>. 2020 Jan 20. pii: S0363-0188(20)30014-1.</li>_x000D_ <li>Schernthaner G, Groop PH, Kalra PA, Ronco C, Taal MW. Sodium-glucose linked transporter-2 inhibitor renal outcome modification in type 2 diabetes: Evidence from studies in patients with high or low renal risk. <a href="https://www.ncbi.nlm.nih.gov/pubmed/32037647"><span class="jrnl" title="Diabetes, obesity &amp; metabolism">Diabetes Obes Metab</span></a>. 2020 Feb 9.</li>_x000D_ </ul>